SXR8:F:F-iShares Core S&P 500 UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 593.2

Change

+7.34 (+1.25)%

Market Cap

USD 98.13B

Volume

79.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.28 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.46 (+0.90%)

USD 114.95B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.51 (+0.91%)

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUAA:F Vanguard S&P 500 UCITS Acc

+2.06 (+1.97%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+6.73 (+6.72%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.74%)

USD 40.89B
0ZC:F Zscaler Inc

+6.16 (+3.41%)

USD 37.92B
BSND:F Danone SA

-0.10 (-0.78%)

USD 33.83B

ETFs Containing SXR8:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 30.72% 91% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.72% 91% A- 80% B-
Trailing 12 Months  
Capital Gain 37.78% 89% A- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.78% 89% A- 76% C+
Trailing 5 Years  
Capital Gain 114.22% 98% N/A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 114.22% 98% N/A 85% B
Average Annual (5 Year Horizon)  
Capital Gain 17.08% 92% A 79% B-
Dividend Return 17.08% 90% A- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 16.22% 34% F 74% C
Risk Adjusted Return 105.32% 97% N/A 97% N/A
Market Capitalization 98.13B 100% F 98% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.